BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: John LM, Dalsgaard CM, Jeppesen CB, Conde-Frieboes KW, Baumann K, Knudsen NPH, Skov PS, Wulff BS. In vitro prediction of in vivo pseudo-allergenic response via MRGPRX2. J Immunotoxicol 2021;18:30-6. [PMID: 33570451 DOI: 10.1080/1547691X.2021.1877375] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Al Hamwi G, Riedel YK, Clemens S, Namasivayam V, Thimm D, Müller CE. MAS-related G protein-coupled receptors X (MRGPRX): Orphan GPCRs with potential as targets for future drugs. Pharmacology & Therapeutics 2022;238:108259. [DOI: 10.1016/j.pharmthera.2022.108259] [Reference Citation Analysis]
2 Mackay GA, Fernandopulle NA, Ding J, McComish J, Soeding PF. Antibody or Anybody? Considering the Role of MRGPRX2 in Acute Drug-Induced Anaphylaxis and as a Therapeutic Target. Front Immunol 2021;12:688930. [PMID: 34867939 DOI: 10.3389/fimmu.2021.688930] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Kolkhir P, Elieh-Ali-Komi D, Metz M, Siebenhaar F, Maurer M. Understanding human mast cells: lesson from therapies for allergic and non-allergic diseases. Nat Rev Immunol 2021. [PMID: 34611316 DOI: 10.1038/s41577-021-00622-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 19.0] [Reference Citation Analysis]